e-cigarettes: lessons for inhalation technologists

32
e-cigarettes: What can inhalation technologists learn from them? Philippe Rogueda - 7 July 2016 @ 3i seminar Chiesi In collaboration with Dr. Philip Chi Lip Kwok and Ms. Lu Hou The University of Hong Kong 1 © Copyright Aedestra Ltd 2016. All rights reserved. Inhalation products made easy www.aedestra.com

Upload: philippe-rogueda

Post on 19-Jan-2017

592 views

Category:

Science


1 download

TRANSCRIPT

e-cigarettes:Whatcaninhalationtechnologists

learnfromthem?PhilippeRogueda- 7July2016

@3iseminarChiesi

IncollaborationwithDr. PhilipChiLipKwokandMs.LuHouTheUniversityofHongKong

1©CopyrightAedestraLtd2016.Allrightsreserved.

Inhalationproductsmadeeasy

www.aedestra.com

Disclaimer&CopyrightsTheinformationcontainedinthispresentation iscopyrighted.

Copyrights:Allcopyrightsreserved.AedestraLtd,2016.

Viewersmayusethe informationcontainedwithintheseslidesforinternalpurposesaccordingtocopyrightslawsofHongKong.Theymaynotusenordistributetheinformationtoanythirdpartywithout Aedestra’s explicitconcern.ReferencetoAedestra’s authorshipandcopyrightownershipmustbemadeinanyprivateorpublicdisclosure.

Thispresentationcontainsthepersonalopinionsandthoughts ofthepresentersandmaynotbeassumedtorepresenttheopinionofAedestraLtdnorofanyemployerorcompanyorlearnedsocietywithwhomthepresentersmightbeormighthavebeenassociated.

AedestraLtdmakesnorepresentationtotheaccuracyofthe informationcontainedtherein.

AedestraLtddeclinesanyresponsibilityontheuseoftheinformationcontainedintheseslides.

AedestraLtddoesnotrecommendanycourseofactionresultingdirectlyorindirectlyfromtheinformationpresentedintheseslides.

©CopyrightAedestraLtd2016.Allrightsreserved. 2

©CopyrightAedestraLtd2016.Allrightsreserved.

Aedestra isaproductdevelopment companyinthefieldof inhaleddrugproduct.

Wemakedeveloping inhaledproductseasy,soyoucan focusondelivery.Wedriveinitiatives;you realise opportunities.

Weguideclientstodevelop therightproductintherightwaybyprovidingstrategic andtechnicalexpertise: reducing cost,timeandrisk.

3

©CopyrightAedestraLtd2016.Allrightsreserved.

Contentoutline

4

e-cigs:thecontext

e-liquids

Devices

Performance

Whatcanwelearn?

©CopyrightAedestraLtd2016.Allrightsreserved.

e-cigs:acontext

5

e-ci

gs c

onte

xt

Theglobale-cigarettemarketisexpectedtogrowover$50billionby2025,atanestimatedCAGRof22.36%from2015to2025.Themarketwillwitnessastaggeringgrowthuntil2017,bywhenmostoftheregulatoryandpolicyframeworkwillfallintoplace.Thegrowthratewillsignificantly increasethereafter,withsignificant revenuegenerationfromevolvingmarketsofAPACandEurope.(http://www.prnewswire.com/news-releases/global-e-cigarette--vaporizer-market-2015-2025---analysis--forecasts-for-the-50-billion-industry-300124050.html)

Agrowingmarketthatischangingbecauseofnewregulations.

e-liquidsanddevicesaremostlyunregulatedanduntil recentlydidnotneedtofollowanyregulations.

Somecountrieshavebannede-cigarettes:Singapore.Otherswouldliketo:HongKong.

©CopyrightAedestraLtd2016.Allrightsreserved.

e-cigs:acontext

6

e-ci

gs c

onte

xt

9March2016- https://www.statista.com/chart/4475/the-state-of-e-cigarette-consumption-in-britain/

©CopyrightAedestraLtd2016.Allrightsreserved.

e-cigs:acontext

7

e-ci

gs c

onte

xt

45MsmokersintheUS.2,75Millione-cigarettessmokers.

29%ofpeopleoftrye-cigarettesquitsmokingafter6months.

Year e-cigsannualsalesUS$

2015 2,875,000,000

2014 1,700,00,000

2013 1,000,000

2012 500,000,000

2011 195,000,000

2010 82,000,000

2009 39,000,000

2008 20,000,000

USA– 2014- http://www.statisticbrain.com/electronic-cigarette-statistics/

©CopyrightAedestraLtd2016.Allrightsreserved.

e-cigs:acontext

8

e-ci

gs c

onte

xt

“OutofJuice:Salesofe-cigarettedeviceslikecigarettesdownconsiderablyin2015”17Nov2015– WallStreetJournalhttp://www.wsj.com/articles/e-cig-sales-rapidly-lose-steam-1447798921

©CopyrightAedestraLtd2016.Allrightsreserved.

e-cigs:acontext

9

e-ci

gs c

onte

xt

NewregulationfromtheFDA,5May2016.

http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm499234.htm

Theserequirements include:

-Registeringmanufacturingestablishmentsandproviding product listingstotheFDA;

-Reportingingredients, andharmfulandpotentiallyharmfulconstituents;

-RequiringpremarketreviewandauthorizationofnewtobaccoproductsbytheFDA.

©CopyrightAedestraLtd2016.Allrightsreserved.

e-liquids

10

e-liq

uids

Fromwww.e-liquidaustralia.com

©CopyrightAedestraLtd2016.Allrightsreserved.

e-liquids

11

e-liq

uids

E-liquidscomposition: 5basicingredients

Glycerol+Propyleneglycol+Water+Nicotine+Flavourings

“Food-approvedsubstances”

Andahostofcontaminants-additives:nitrosamines (fromnicotine),aldehydes,solvents, colorings, andheavymetalscomingfromthedeviceortheingredients.

Phys.Chem.Properties:Glycerol:Bp 290oC(C3H8O3,MW92.09)Propyleneglycol:Bp 188oC(C3H8O2,MW76.09)Nicotine:Bp 247oC (C10148B2,MW162.23)

Glycerolandpropylene glycolareusedinartificialtheatricalsmokeandasadditivesintobaccocigarettes.

©CopyrightAedestraLtd2016.Allrightsreserved.

e-liquids

12

e-liq

uids

Onenametoremember:KonstantinosFarsalinos.

Thetoxicityofe-liquids seemstostemfromflavourings.

Propyleneglycolandglycerolarecurrentlynotareasonforconcern,although theirlong termeffectsonthelungshavenotbeenstudied.

Nicotineine-cigsisnotareasonforconcern,expectthattheircontentisnotalwaysfullycontrolled.

“Glycerinhasbeen identifiedasanaturalcomponentoforientaltobacco(0.34–0.48%),flue-cured tobaccos(0.07–0.12%),andburley(0.23–0.31%)…Inthecigarette,glycerinhelps toretainmoistureandpreventsdryingoutofthetobacco.Glycerinistypicallyapplied totobaccoatlevelsof1–5%”.Toxicologicalevaluationofglycerinasacigaretteingredient.E.L.Carmines,C.L.Gaworski.FoodandChemicalToxicology43(2005)1521–1539.

©CopyrightAedestraLtd2016.Allrightsreserved.

Toxicityofe-liquids

13

Perf

orm

ance

Toxicityofe-liquidscanstemfrom:-thedegradationofglycerine andpropyleneglycol-solvents-heavymetals

….but mostlyfromflavourings.

Levelsofselectedcarcinogensandtoxicantsinvapour fromelectroniccigarettes.Maciej LukaszGoniewicz etal.Tobaco Control.TobControl doi:10.1136/tobaccocontrol-2012-050859.

©CopyrightAedestraLtd2016.Allrightsreserved.

Devices

14

Dev

cies

2013BackgroundPaperonE-cigarettesElectronicNicotineDeliverySystems(https://escholarship.org/uc/item/13p2b72n#page-5)

©CopyrightAedestraLtd2016.Allrightsreserved.

Devices

15

Dev

cies

Battery+Atomizer+Tank+Mouthpiece

©CopyrightAedestraLtd2016.Allrightsreserved.

Devices

16

Dev

cies

Atypicalcigaretteburnsofftobaccoat~900oC.

Anelectroniccigaretteresistancewould typicallyreach200-400oC.

Devicesareveryunreliable.

Theaerosolisation mechanismofe-cigsismostlyunknown:evaporation/condensation? Buthow?Whatdropletsaregenerated?Deviceshavehigh resistance,howdoesthisaffectdeposition?

Dodevicesproducenano ormicroparticles?

Mostofthetestsoncigarettesande-cigsusefiltersoronly reportdatabelow1um,oftenbelow100nm.

©CopyrightAedestraLtd2016.Allrightsreserved.

Devices

17

Dev

cies

Kimree,madeinChina:cartomizer

Cartomizer(wickbasedsystem):layersofgauzearewrappedaroundacentertubewithawickandaverticalheatingcoil.Thegauzesaturatesthewick,andtheheatingcoilvaporizestheliquid.

©CopyrightAedestraLtd2016.Allrightsreserved.

Devices

18

Dev

cies

©CopyrightAedestraLtd2016.Allrightsreserved.

Performance

19

Perf

orm

ance

Measurements:-TryingtobringPharm.Sci.methodsintotheworldofvaping.-SYMPATECInhaler&Helos.-flowrate:2L/min.-NoNGI/ACImeasurementatthisstage.

Liquids:-mixturesofwater,EtOH,glycerol,propyleneglycol.-nonicotine.-noflavouring.

Deviceused:commercialdevice:Kimree,singleuse.

#8 #14

water 14.33% 25%

EtOH 0.14% 25%

Glycerol 71.33% 25%

PropyleneGlycol 14.33% 25%

©CopyrightAedestraLtd2016.Allrightsreserved.

Performance

20

Perf

orm

ance

Glycerine/propylene glycoldrivetheaerosolisation.Particlesareinthemicrometerrange.Ourresultsindicateminimalnanoparticles ...thequestion iswhy?

©CopyrightAedestraLtd2016.Allrightsreserved.

Performance

21

Perf

orm

ance

Results:-testdonewithoutnicotine.-cannotvaporise purewater.-propyleneglygol andglycerincontrolthevapingprocess.-dropletsofglycerol/glycerinareintherespirablerange.-dropletsarelargerthanclaimbyBritishAmericanTobacco.

Discussion/questions:-whyarethedropletswemeasuresolarge?-whyareothertestsevidencingnanodroplets?-wherewouldthenicotinebefound? Asavapour? Inthedroplets?-isthislungdelivery?orsublingualdelivery?-whatistheroleofthenanodroplets inenhancingdelivery?-whatcanwedototranslatethevapingdevicesandtheuseofpropyleneglycolandglycerintoOINDPs?

©CopyrightAedestraLtd2016.Allrightsreserved.

Performance

22

Perf

orm

ance

Dropletsizemeasurementofe-cigaretteaerosols.KevinMcAdam,RossCabot,JessicaHunt,CanerUYurten,JohnMcAughey.FirstGlobalForumOnNicotine,Warsaw,Poland:27-28June2014

Influentialparametersonparticleconcentrationandsizedistribution inthemainstreamofe-cigarettes.F.C.Fuoco,G.Buonanno, L.Stabile,P.Vigo.EnvironmentalPollution 184(2014)523e529.

E-cigsvs.traditionalcigarettes:nomicro-droplets!...why?

©CopyrightAedestraLtd2016.Allrightsreserved.

Performance

23

Perf

orm

ance

Nanoparticlesincigarettesmoke;real-timeundilutedmeasurementsbyascanningmobilityparticlesizer.WouterD.vanDijk &SimoneGopal&PaulT.J.Scheepers.AnalBioanal Chem(2011)399:3573–3578.

E-cigsvs.traditionalcigarettes:whathappensabove100nm?Traditionalcigarettesarefiltered.Aremeasurementsmethodscorrect?

©CopyrightAedestraLtd2016.Allrightsreserved.

Performance

24

Perf

orm

ance Comparison ofthe

aerosolproducedbyelectroniccigaretteswithconventionalcigarettesandtheshisha.J.-F.Bertholona,M.H.Becquemina,M.Roya,F.Royd,D.Ledure,I.Annesi Maesanof,B.Dautzenberg.RevuedesMaladiesRespiratoires(2013)30,752—757

E-cigsvs.cigarettes.:nomicrodroplets.

Wasafilterusedwiththee-cigs?…orarethemethodspredictiveof theresults?(i.e.onecanonlyfindwhatoneislooking for).

©CopyrightAedestraLtd2016.Allrightsreserved.

Performance

25

Perf

orm

ance

Evaporationandcondensation ofmulticomponent electronicCigarettedropletsandconventional cigarettesmokeparticlesinanidealizedG3–G6triplebifurcatingunit.Y.Feng,C.Kleinstreuer,A.Rostami.Journal ofAerosolScience80(2015)58–74

Onemodelseemstoindicatemicroparticles.Theoreticalstudiesofwater/glycerol/propyleneglycol/nicotinemixtures.

©CopyrightAedestraLtd2016.Allrightsreserved.

Performance

26

Perf

orm

ance

Theaerosolcharacteristicsofcigarettesisusuallymeasuredin“density”oropticalparameters,appropriateforasmoke/gascloud,butnotmuchusefore-cigsthataredroplets.

Thefewparticle/dropletdiameteranalysisfromtheliteratureindicatenanoparticles.Wedonotseethese.

Thereisamethod issue:thevaping/tobaccoindustryusesinstruments fitfordroplets<1um,weuseawiderrange.Theyusefiltersoncigarettes,wedon’t.

Thevaping industry isinterestedincomparing theirproducts tocigarettes,isthisskewingtheresults?

Knowing thecorrectparticlesizeandaerosolisation mechanism isimportant tounderstand theriskandbenefitsofe-cigsasadeliverysystems.

©CopyrightAedestraLtd2016.Allrightsreserved.

Nicotinedelivery

27

Perf

orm

ance

e-cigsdonotdeliverhigherdosesofnicotine

Nicotineabsorption fromelectroniccigaretteuse:comparisonbetweenfirstandnew-generationdevices.Konstantinos E.Farsalinos etal.SciRep.2014;4:4133.

©CopyrightAedestraLtd2016.Allrightsreserved.

Whatcanwelearn?

28

Moo

t poi

nts

E-cigarettesdevelopersareaheadofpharmaceuticalscientistsinformulating withnewexcipients.Vapingdevicesoffernewdeliverytechnology.Thelargescaleuseofpropyleneglycolandglycerine opensnewformulation horizons.Theiruseshouldbemonitored: thisisaworldwiderealscaleinvivoclinical/epidemiology study.Arewewitnessingnanodroplet lungdelivery?

Theperformanceandreliabilityofe-cigarettesispoor ifnotrandom.Theaerosolisation mechanismisnotunderstood.Morelikelytobeevaporation/condensation driven.Sub-lingualorlungdelivery?: thatisamootpoint.Flavouring canonlybefeltinthemouthorsmeltviathenose,isthatduetolargedroplets?Nicotineabsorption canbeeffectiveviathemouthorviathelungs.

Clinicalefficacyisanecdotalbutcouldbereal.e-cigshaveabettersafetyprofile thancigarettes,butmaybeequallyaddictiveandbring innewdegradationproducts.

Merxin is a generic inhaler device supplier that supplies off-the-shelf generic devices to accelerate and reduce the cost of the development inhaled products.

MRX001 a generic version of Diskus® is its leading product.

Merxin Ltd was incorporated in the UK in January 2016.

Merxin is currently raising funds and clients’ interest.

Philippe Rogueda is a co-founder and director of Merxin Ltd.

MerxinLtd

Generic Medical Devices Made Easy

www.merxin.com

THELEADINGOPENACCESSNETWORKOFINHALATIONDRUGDELIVERYSPECIALISTS

www.inhalationasia.org

InhalationAsia:TheleadingopenaccessnetworkofinhalationadrugdeliveryspecialistsinAsia.Aconferenceoninhalationdrugdeliverytechnologyevery2years.Founded in2011byPhilippeRogueda(CEO)and3partnersinIndia,ChinaandtheUK.BlogonTwitter,WeChatandLinkedIn.

Nextconference:

Inhalatio

nAsia

InhalationAsia201713-15September2017

HongKong

© Copyright Aedestra Ltd 2016. All rights reserved.

Contact

[email protected]

+447975619544+33641942038

Generalenquiries: [email protected]

FollowourblogonTwitter@Aedestraandonline:http://aedestra.com/blog

www.aedestra.com

Scan this code to contact us:

inhalation products made easy